HVTN 502/Merck 023 - The Step Study
A Phase II Proof of Concept HIV Vaccine Study
This is a study of an experimental vaccine that may one day prevent HIV infection or keep people who do become infected healthier.
Volunteers cannot become infected with HIV or get AIDS by receiving the study vaccine. The vaccine is not made from whole virus, weakened virus or live virus, nor does it contain cells infected with HIV.
About 3,000 people will be enrolled in this study in the United States, Canada, South America, the Caribbean and Australia.
Who can participate in this study in New York City?
-HIV negative men who have sex with other men, who are generally healthy and between the ages of 18 and 45 years.
-HIV negative women who have sex with men and are generally healthy and between the ages of 18 and 45 years.
How long does the study last?
4 1/2 years, consisting of about 16 visits. After the first year visits are once every six months.
Benefits of Participation:
-HIV risk reduction counseling and testing
-Reimbursement for time and travel.
-Participation in advanced HIV prevention research |
Who should I contact if I want to know more about this study?
We encourage potential volunteers to contact us to discuss the study at length. For complete information, or to join the trial, contact:
Project ACHIEVE in lower Manhattan
212-388-0008, or
Project ACHIEVE in the Bronx
718-402-0743 or
Columbia University
HIV Prevention & Treatment Research
212-305-2201. |
|
HVTN 063 - Phase I HIV Vaccine Study
This is a clinical trial to test the safety and immune response to an experimental HIV vaccine.
The trial will test whether the study vaccines are well tolerated, and whether they cause an immune response.
Volunteers in this study cannot become infected with HIV or get AIDS by receiving the vaccines in the study. The products in the study are not produced from live virus or from HIV-infected human cells.
Who can participate in this study in New York City?
-HIV negative men and women who are generally healthy and between the ages of 18 and 45 years.
How long does the study last?
12 - 18 months
Benefits of Participation:
-HIV risk reduction counseling and testing
-Reimbursement for time and travel.
-Participation in advanced HIV prevention research |
Who should I contact if I want to know more about this study?
We encourage potential volunteers to contact us to discuss the study at length. For complete information, or to join the trial, contact:
Project ACHIEVE in lower Manhattan
212-388-0008, or
Project ACHIEVE in the Bronx
718-402-0743 or
Columbia University
HIV Prevention & Treatment Research
212-305-2201.
More information on HVTN 063 is available at: http://www.hvtn.org/faq/063/hvtn063en.pdf |
|
HVTN 068 - Phase I HIV Vaccine Study
This is a clinical study to evaluate safety and the immune response to two HIV vaccines.
Volunteers in this study cannot become infected with HIV or get AIDS by receiving the vaccines in the study. The products in the study are not produced from live virus or from HIV-infected human cells.
Who can participate in this study in New York City?
-HIV negative men and women who are generally healthy and between the ages of 18 and 45 years.
How long does the study last?
12 months
Benefits of Participation:
-HIV risk reduction counseling and testing
-Reimbursement for time and travel.
-Participation in advanced HIV prevention research
|
Who should I contact if I want to know more about this study?
We encourage potential volunteers to contact us to discuss the study at length. For complete information, or to join the trial, contact:
Project ACHIEVE in lower Manhattan
212-388-0008, or
Project ACHIEVE in the Bronx
718-402-0743 or
Columbia University
HIV Prevention & Treatment Research
212-305-2201.
More information on HVTN 063 is available at: http://www.hvtn.org/faq/063/hvtn063en.pdf
|
|
|
Project MIX
 According to current information gay and bisexual men continue to be the largest risk group for new HIV infections and for existing cases of HIV and AIDS in the Unites States. Although several studies have shown a connection between alcohol and drug use and risky sexual behavior among gay and bisexual men few studies have focused specifically on reducing the sexual risk of gay and bisexual men who use alcohol or drugs.
Project MIX is a group intervention for HIV positive and negative gay and bisexual men who use alcohol or drugs. The goal of the intervention is to reduce unprotected sex while under the influence of alcohol and other drugs.
Who can participate in this study in New York City?
HIV negative or positive men, aged 18+ years, who have sex with other men, and use alcohol or drugs.
How long does the study last?
About 18 months overall. An initial interview is followed by six 2-hour group sessions (once a week for six weeks), and by three follow-up appointments at 3 months, 6 months & 12 months respectively.
Benefits of Participation:
-HIV testing and counseling
-Reimbursement for time and travel.
|
Who should I contact if I want to know more about this study?
We encourage potential volunteers to contact us to discuss the study. For information or to join the study, contact Project ACHIEVE’s Union Square site: 212-388-0008.
|
|
UNITY
UNITY is a behavioral intervention study to test the efficacy of enhanced sexual risk reduction counseling and enhanced HIV vaccine education compared with a control condition. The target population for this study is HIV negative women aged 18 and older who are sexually active and using non-injecting drugs.
The study will involve 8 visits over a one year period and include HIV, Hepatitis B and pregnancy testing; risk reduction counseling sessions with a counselor; HIV vaccine education; and Hepatitis B vaccinations (for those who have not already been vaccinated.)
The study begins in the Fall of 2004 and will be completed at the end of 2006. UNITY will be conducted at our Bronx site. For more information about the study, to refer someone, or to receive flyers and brochures to distribute, please call 1-718-402-0743 or 1-800-973-3312.
Funded by the National Institute of Drug Abuse, UNITY is being conducted by Project Achieve in conjunction with investigators at the New York Academy of Medicine and Rutgers University. The Principal Investigator is Beryl Koblin, Ph.D.
Who can participate in this study in New York City?
HIV negative women age 18 years and over who are sexually active and using non-injecting drugs.
How long does the study last?
The study lasts one year and has 8 visits.
Benefits of Participation:
-HIV, Hepatitis B and pregnancy testing
-Risk reduction counseling
-Hepatitis B vaccinations (if not already vaccinated)
-HIV Vaccine education
|
Who should I contact if I want to know more about this study?
We encourage potential volunteers to contact us to discuss this study at length. For complete information or to join the study, contact Project ACHIEVE’s Bronx site: 718-402-0743
|
|
|
ONGOING
STUDIES 
